The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

[1]  Paul Schoenhagen,et al.  The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. , 2010, Archives of internal medicine.

[2]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[3]  Y. Hwang,et al.  Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. , 2009, International journal of cardiology.

[4]  S. Wild,et al.  Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. , 2009, Atherosclerosis.

[5]  Y. Kokubo,et al.  Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[6]  O. Kirk,et al.  Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study) , 2009, Circulation.

[7]  A. Mykletun,et al.  Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT) , 2009, Diabetologia.

[8]  C. Forsblom,et al.  Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes , 2009, Diabetes Care.

[9]  J. Tuomilehto,et al.  Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts , 2009, Stroke.

[10]  S. Lévesque,et al.  Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronary-angiographic alterations , 2009, Coronary artery disease.

[11]  D. Liao,et al.  Metabolic Syndrome Clusters and the Risk of Incident Stroke: The Atherosclerosis Risk in Communities (ARIC) Study , 2009, Stroke.

[12]  Y. Kokubo,et al.  Impact of Metabolic Syndrome Components on the Incidence of Cardiovascular Disease in a General Urban Japanese Population: The Suita Study , 2008, Hypertension Research.

[13]  A. Pereira,et al.  Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study , 2008, Coronary artery disease.

[14]  K. Takazawa,et al.  Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[15]  E. Tai,et al.  The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study , 2008, Clinical endocrinology.

[16]  B. Pannier,et al.  All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. , 2008, The American journal of cardiology.

[17]  C. Wen,et al.  The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly , 2008, European journal of clinical investigation.

[18]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[19]  B. Pannier,et al.  The metabolic syndrome: similar deleterious impact on all-cause mortality in hypertensive and normotensive subjects , 2008, Journal of hypertension.

[20]  D. Balzi,et al.  Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal study. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  D. Mozaffarian,et al.  Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. , 2008, Archives of internal medicine.

[22]  M. Laakso,et al.  The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland , 2008, Stroke.

[23]  P. Hsu,et al.  Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study. , 2008, Diabetes research and clinical practice.

[24]  Long‐Teng Lee,et al.  All‐cause and Cardiovascular Disease Mortality Increased With Metabolic Syndrome in Taiwanese , 2008, Obesity.

[25]  W. Spiering,et al.  Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients , 2008, Journal of Human Hypertension.

[26]  T. Kurata,et al.  Impact of Metabolic Syndrome among Patients with and without Diabetes Mellitus on Long-Term Outcomes after Percutaneous Coronary Intervention , 2008, Hypertension Research.

[27]  S. Tanomsup.  O103 A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand , 2008 .

[28]  L. Shaw,et al.  Depression, the Metabolic Syndrome and Cardiovascular Risk , 2008, Psychosomatic medicine.

[29]  R. Sacco,et al.  Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study , 2008, Stroke.

[30]  Y. van der Graaf,et al.  Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. , 2007, European heart journal.

[31]  J. Manson,et al.  Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. , 2007, The American journal of cardiology.

[32]  T. Davis,et al.  Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. , 2007, Diabetes research and clinical practice.

[33]  D. Cooper,et al.  Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection , 2007, AIDS.

[34]  K. Kayaba,et al.  Metabolic Syndrome Mortality in a Population-Based Cohort Study: Jichi Medical School (JMS) Cohort Study , 2007, Journal of epidemiology.

[35]  S. Haffner,et al.  The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. , 2007, Annals of epidemiology.

[36]  K. Chien,et al.  Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. , 2007, Atherosclerosis.

[37]  R. Devereux,et al.  Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study , 2007, Journal of Human Hypertension.

[38]  Y. Duan,et al.  Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all‐cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities study , 2007, Journal of internal medicine.

[39]  Mahbubur Rahman,et al.  Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study , 2007, Stroke.

[40]  S. Blankenberg,et al.  Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. , 2007, The American journal of cardiology.

[41]  C. Barbagallo,et al.  The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. , 2007, Atherosclerosis.

[42]  J. Murabito,et al.  Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes , 2007, Diabetes.

[43]  K. Yamagishi,et al.  Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women , 2007, Stroke.

[44]  K. Asayama,et al.  Out-of-office blood pressure control among treated subjects. , 2007, Hypertension.

[45]  T. Hansen,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. , 2007, Journal of the American College of Cardiology.

[46]  B. Cheung,et al.  Metabolic syndrome increases all‐cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study , 2007, Clinical endocrinology.

[47]  C. Tzavara,et al.  Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population. , 2007, American journal of hypertension.

[48]  B. Hedblad,et al.  The metabolic syndrome and incidence of cardiovascular disease in non‐diabetic subjects—a population‐based study comparing three different definitions , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[49]  M. Laakso,et al.  The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. , 2007, European heart journal.

[50]  S. Grundy,et al.  Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. , 2007, American heart journal.

[51]  Y. Friedlander,et al.  Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study , 2007, The Medical journal of Australia.

[52]  M. Hori,et al.  Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. , 2007, The American journal of cardiology.

[53]  B. Balkau.  Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study: The Diabetes Epidemiology: Collaborative analysis Of Diagnostic Criteria in Europe (DECODE) Study Group , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[54]  D. Tanné,et al.  Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. , 2007, The American journal of cardiology.

[55]  A. Cheung,et al.  Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  G. Can,et al.  Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation , 2007, International Journal of Obesity.

[57]  S. Grundy.  Controversy in Clinical Endocrinology Metabolic Syndrome: a Multiplex Cardiovascular Risk Factor Mets as a Multiplex Cardiovascular Risk Factor , 2022 .

[58]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[59]  G. Mancia,et al.  Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis , 2007, Hypertension.

[60]  R. Weinstock,et al.  The metabolic syndrome: concepts and controversy. , 2006, Mayo Clinic proceedings.

[61]  T. Kurata,et al.  Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[62]  Chih-jen Wu,et al.  Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome , 2006, Coronary artery disease.

[63]  Harukazu Tsuruta,et al.  Development and validation of MIX: comprehensive free software for meta-analysis of causal research data , 2006, BMC medical research methodology.

[64]  Karl-Heinz Jöckel,et al.  Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices , 2006, German medical science : GMS e-journal.

[65]  Jiang He,et al.  Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. , 2006, The American journal of medicine.

[66]  E. Barrett-Connor,et al.  Cardiovascular Death and the Metabolic Syndrome , 2006, Diabetes Care.

[67]  J. Manson,et al.  Conjugated equine estrogens and coronary heart disease : The women's health initiative , 2006 .

[68]  S. Maggi,et al.  Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[69]  S. Rubin,et al.  Metabolic syndrome and the risk of cardiovascular disease in older adults. , 2006, Journal of the American College of Cardiology.

[70]  C. Bai,et al.  Influence of Metabolic Syndrome and General Obesity on the Risk of Ischemic Stroke , 2006, Stroke.

[71]  L. Lind,et al.  Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study , 2006, BMJ : British Medical Journal.

[72]  S. Fuchs,et al.  Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio , 2006, Menopause.

[73]  L. Niskanen,et al.  Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men , 2006, Stroke.

[74]  Ian Janssen,et al.  The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. , 2006, Diabetes care.

[75]  J. Tardif,et al.  The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. , 2006, American heart journal.

[76]  Richard W Morris,et al.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.

[77]  Paul Zimmet,et al.  [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. , 2005, Revista espanola de cardiologia.

[78]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[79]  J. Cauley,et al.  Increased mortality associated with the metabolic syndrome in older women with diabetes. , 2005, Diabetes care.

[80]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[81]  L. Bouter,et al.  Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study , 2005, Circulation.

[82]  L. Tavazzi,et al.  Metabolic syndrome and risk of cardiovascular events after myocardial infarction. , 2005, Journal of the American College of Cardiology.

[83]  D. Tanné,et al.  Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack: A Prospective Cohort Study in Patients With Atherosclerotic Cardiovascular Disease , 2005, Stroke.

[84]  S. Takagi,et al.  Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese Men—The Tanno and Sobetsu Study , 2005, Hypertension Research.

[85]  Ian Janssen,et al.  Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. , 2005, Diabetes care.

[86]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[87]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[88]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[89]  E. Mannarino,et al.  Prognostic value of the metabolic syndrome in essential hypertension. , 2004, Journal of the American College of Cardiology.

[90]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[91]  S. Rubin,et al.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. , 2004, Diabetes.

[92]  S. Reis,et al.  Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women: A Report From the Women’s Ischemia Syndrome Evaluation , 2004, Circulation.

[93]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[94]  A. Gotto,et al.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.

[95]  J. Hsia,et al.  Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial. , 2003, American heart journal.

[96]  Mary Cushman,et al.  Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[97]  Richard S Legro,et al.  Polycystic ovary syndrome and cardiovascular disease: a premature association? , 2003, Endocrine reviews.

[98]  J. Després,et al.  Waist circumference, visceral obesity, and cardiovascular risk. , 2003, Journal of cardiopulmonary rehabilitation.

[99]  B. Howard,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. , 2003, Diabetes care.

[100]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[101]  P. Ridker,et al.  Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women , 2002, Circulation.

[102]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[103]  E. Ferrannini,et al.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.

[104]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[105]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[106]  J. Stockman.  How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis , 2009 .

[107]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[108]  S. Yasuda,et al.  Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: potential association with C-reactive protein. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[109]  H. Bokura,et al.  Metabolic syndrome increases the risk of ischemic stroke in women. , 2007, Internal medicine.

[110]  B. Drolet,et al.  Impact of Weight-Loss Medications on the Cardiovascular System , 2007, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[111]  C. Byrne,et al.  Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes , 2005, Diabetologia.

[112]  G. Reaven.  Banting lecture 1988 , 1997 .